SELVAS Healthcare, Inc.
Financials
Valuation Metrics
SELVAS Healthcare, Inc.'s Market Cap is ₩698B. At end of 2025 it was ₩1496B. Ranked #1493 of 2,436 in KR market (top 61%), #857 of 1,649 on KOSDAQ (top 52%), #56 of 96 in Health Care Equipment & Services (top 58%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 69.76B KRW | KR#1,493/2,436 Sec#56/96 |
| Revenue | 30.19B KRW | KR#2,026/2,436 Sec#63/96 |
| Net Income | 16.92B KRW | KR#709/2,436 Sec#17/96 |
| Total Assets | 92.20B KRW | KR#1,810/2,436 Sec#54/96 |
| Net Assets | 84.43B KRW | KR#1,515/2,436 Sec#44/96 |
| Employees | 132 | KR#1,421/2,436 Sec#49/96 |
| Value | ||
| P/E | 4.12x | KR#211/2,436 Sec#2/96 |
| P/B | 0.83x | KR#1,321/2,436 Sec#26/96 |
| PEG | 0.00x | KR#7/2,436 Sec#1/96 |
| P/S | 2.31x | KR#1,897/2,436 Sec#55/96 |
| EV/EBITDA | 421.05x | KR#1,550/2,436 Sec#52/96 |
| FCF Yield | -0.79% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | 20.04% | KR#127/2,436 Sec#7/96 |
| ROA | 18.35% | KR#39/2,436 Sec#2/96 |
| Op. Margin | 0.52% | KR#1,541/2,436 Sec#51/96 |
| Revenue Growth | -8.76% | KR#1,833/2,436 Sec#73/96 |
| Earnings Growth | 6714.74% | KR#12/2,436 Sec#2/96 |
| Financial Health | ||
| Debt Ratio | 109.20% | KR#421/2,436 Sec#18/96 |
| Total Debt | 749.9M KRW | KR#1,986/2,436 Sec#78/96 |
| FCF | -552.0M KRW | KR#1,258/2,436 Sec#37/96 |
| Cash | 4.00B KRW | KR#2,077/2,436 Sec#78/96 |
| Current Ratio | 11.96x | KR#75/2,436 Sec#8/96 |
| Net Debt/EBITDA | -20.56x | KR#33/2,436 Sec#3/96 |
| Performance | ||
| 1Y Return | -35.01% | KR#1,704/2,436 Sec#54/96 |
| 1M Return | -4.75% | KR#1,373/2,436 Sec#62/96 |
| From 52W High | -63.82% | KR#1,897/2,436 Sec#67/96 |
| 1Y MDD | -67.14% | KR#1,801/2,436 Sec#64/96 |
| Trading | ||
| Volume | 492,443 shares | KR#277/2,436 Sec#7/96 |
| Foreign Own. | 5.12% | KR#786/2,436 Sec#28/96 |
| Per Share | ||
| EPS | 657 KRW | KR#801/2,436 Sec#20/96 |
| BPS | 3,283 KRW | KR#1,751/2,436 Sec#49/96 |
Company Info
Selvas Healthcare was established in 1999 to develop and sell medical diagnostic devices and visual assistive technology devices, enhancing its technological capabilities through a 2015 merger with Jawon Medical. The company operates two divisions: Accuniq, for body composition analyzers and automatic blood pressure monitors, and Himss, which produces braille information terminals and reading magnifiers for the visually impaired. Leveraging 30 years of technological expertise, Selvas Healthcare is growing as a specialized digital healthcare company, expanding into international markets via partnerships with fitness distribution channels. Selvas Healthcare was established in 2014 and is headquartered in Yuseong-gu, Daejeon.